Systematic Review and Meta-Analysis of the Efficacy and Safety of Amfepramone and Mazindol As a Monotherapy for the Treatment of Obese or Overweight Patients. Clinics 2017, 72 (5), 317-324. https://doi.org/10.6061/clinics/2017(05)10.